immunology
-
September 12, 2022
Enhancing innate immunity in the lung
Vanderbilt researchers show that a TLR4 agonist improves lung immune response and survival in a mouse model of bacterial pneumonia, supporting the development of this drug to protect against pneumonia in hospitalized patients. -
September 1, 2022
Study identifies key player in T cell “education”
New Vanderbilt research could inform therapeutic strategies for enhancing thymic function when desired — such as during aging, recovery from radiation therapy or chemotherapy, or other conditions that reduce T cell output. -
July 20, 2022
Vanderbilt team tracks cellular and antibody responses to COVID-19 vaccine
In a technical tour de force, a collaborative team of Vanderbilt researchers has characterized the antigen-specific immune response to the Pfizer SARS-CoV-2 RNA vaccine. -
June 3, 2022
Food allergy linked to lower risk of SARS-CoV-2 infection
-
June 2, 2022
Bacterial battle in 3D
Using imaging mass spectrometry and microscopy, Vanderbilt researchers visualized how staph bacteria modifies lipids in its membrane to evade immune system-mediated killing. -
April 21, 2022
Youthful healing for burn wounds
Topical treatment of burns with an immunosuppressive drug counteracted the negative effects of aging on wound healing, Vanderbilt researchers have discovered. -
March 28, 2022
Study finds 10-second videos predict blood cancer relapse
Vanderbilt research shows that 10-second videos of white blood cell motion in the skin’s microvasculature greatly improved the prediction of which stem cell and bone marrow transplant patients would have a relapse of their blood cancer.